This should be the first report identifying ATG10 rs10514231, rs1864183, rs4703533, and ATG16L2 rs10898880 could contribute to the efficacy and toxicities of radiotherapy in NPC patients. This evidence concerns the gene ATG16L2 and nasopharyngeal carcinoma.